跳至主要内容
临床试验/NCT01227122
NCT01227122Unknown不适用

Plasmatic Level of Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Predictive Marker of Acute Kidney Failure in Patients With Preoperative Chronic Kidney Failure Undergoing Cardiac Surgery.

Hopital Jean Minjoz1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2010年8月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
1
主要终点
Neutrophil Gelatinase Associated Lipocalin (NGAL) level

研究概览

简要总结

Primary endpoint: To evaluate predictive value of plasmatic levels of Neutrophil Gelatinase Associated Lipocalin (NGAL) to reveal acute kidney failure after cardiac surgery in patients with preoperative chronic kidney failure Secondary endpoint is to obtain threshold values of NGAL.

详细描述

(N/A)

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Renal clearance less than 60 mL/min
  • Able to give written consent
  • Elective valve surgery
  • Elective CABG surgery

排除标准

  • Less than 18 years old
  • Iodine injection within 3 days before surgery
  • Iodine injection within 24 first postoperative hours
  • preoperative infection
  • evolutive cancer disease
  • Pregnancy
  • Unable to give written consent

结局指标

主要结局

Neutrophil Gelatinase Associated Lipocalin (NGAL) level

时间窗: From surgery to discharge from hospital

次要结局

未报告次要终点

研究者

发起方
Hopital Jean Minjoz
申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Sidney Chocron

MD, PhD

Hopital Jean Minjoz

研究点 (1)

Loading locations...

相似试验